HSA
JNCE

Hussman Strategic Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Hussman Strategic Advisors’s Portfolio JNCE Stock Details JNCE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
2021
Q2 		$105K Buy
2021
Q1 		– Sell
2020
Q4 		$357K Sell
2020
Q3 		$832K Buy